You need to enable JavaScript to run this app.
FDA drafts guidance on using ‘generally accepted’ knowledge to support drug approvals
Regulatory News
Ferdous Al-Faruque
Biologics/ biosimilars/ vaccines
Compliance
North America
Pharmaceuticals
Preclinical study
Regulatory Intelligence/Policy